Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ray

Showing results (111-120 of 229) with videos related to

Pageof 23
Sort By:
British Journal of Cancer|March 1, 2003
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapyI Ray-Coquard, C Borg, Th Bachelot, et al.
Drugs of Today (Barcelona, Spain : 1998)|August 4, 2009
Mapping the literature: role of trabectedin as a new chemotherapy option in advanced pretreated soft tissue sarcomaA Le Cesne, J Domont, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2014
A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinomaF Selle, E Sevin, I Ray-Coquard, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2012
Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trialsS Mahner, C Eulenburg, A Staehle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapyL C Hanker, S Loibl, N Burchardi, et al.
Bulletin Du Cancer|December 17, 2009
[Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France]I Ray-Coquard, P Pautier, E Pujade-Lauraine, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|January 14, 2014
Issues for storing plant-based alternative fuels in marine environmentsJason S Lee, Richard I Ray, Brenda J Little, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2006
Sarcomas and malignant phyllodes tumours of the breast--a retrospective studyC Confavreux, A Lurkin, N Mitton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 16, 2022
Human papillomavirus prevalence, persistence and cervical dysplasia in females with cystic fibrosisC Rousset-Jablonski, Y Mekki, A Denis, et al.
British Journal of Cancer|April 25, 2013
Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECOI Ray-Coquard, L Favier, B Weber, et al.
Pageof 23

Showing results (111-120 of 229) with videos related to

Sort By:
Pageof 23
British Journal of Cancer|March 1, 2003
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapyI Ray-Coquard, C Borg, Th Bachelot, et al.
Drugs of Today (Barcelona, Spain : 1998)|August 4, 2009
Mapping the literature: role of trabectedin as a new chemotherapy option in advanced pretreated soft tissue sarcomaA Le Cesne, J Domont, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2014
A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinomaF Selle, E Sevin, I Ray-Coquard, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2012
Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trialsS Mahner, C Eulenburg, A Staehle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapyL C Hanker, S Loibl, N Burchardi, et al.
Bulletin Du Cancer|December 17, 2009
[Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France]I Ray-Coquard, P Pautier, E Pujade-Lauraine, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|January 14, 2014
Issues for storing plant-based alternative fuels in marine environmentsJason S Lee, Richard I Ray, Brenda J Little, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2006
Sarcomas and malignant phyllodes tumours of the breast--a retrospective studyC Confavreux, A Lurkin, N Mitton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 16, 2022
Human papillomavirus prevalence, persistence and cervical dysplasia in females with cystic fibrosisC Rousset-Jablonski, Y Mekki, A Denis, et al.
British Journal of Cancer|April 25, 2013
Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECOI Ray-Coquard, L Favier, B Weber, et al.
Pageof 23